PET Biomarker Outperforms Established Risk Score in Predicting Survival for Large B-Cell Lymphoma Patients
April 22, 2026
April 22, 2026
RESTON, Virginia, April 22 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:
* * *
PET Biomarker Outperforms Established Risk Score in Predicting Survival for Large B-Cell Lymphoma Patients
Metabolic tumor volume-a biomarker derived from PET imaging-can more accurately predict progression-free survival for large B-cell lymphoma patients than the widely used International Prognostic Index. By id . . .
* * *
PET Biomarker Outperforms Established Risk Score in Predicting Survival for Large B-Cell Lymphoma Patients
Metabolic tumor volume-a biomarker derived from PET imaging-can more accurately predict progression-free survival for large B-cell lymphoma patients than the widely used International Prognostic Index. By id . . .
